Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples
Open Access
- 1 December 2004
- Vol. 53 (12) , 1860-1865
- https://doi.org/10.1136/gut.2004.039784
Abstract
Background: Brush cytology of biliary strictures to diagnose pancreaticobiliary malignancy suffers from poor sensitivity. Aim: To improve the diagnostic yield of pancreaticobiliary brush cytology through analysis of tumour suppressor gene linked microsatellite marker loss of heterozygosity (LOH) and k-ras codon 12 mutation detection. Methods: Twenty six patients with biliary strictures underwent endoscopic retrograde cholangiography with brush cytology. A panel of 12 polymorphic microsatellite markers linked to six tumour suppressor genes was developed. Genomic DNA from cell clusters acquired from brush cytology specimens and microdissected surgical malignant and normal tissue underwent polymerase chain amplification reaction (PCR). PCR products were compared for LOH and k-ras codon 12 mutations. Results: Seventeen patients were confirmed to have pancreaticobiliary adenocarcinoma. Nine patients had benign strictures (eight proven surgically, one by follow up). Cytomorphological interpretation was positive for malignancy (n = 8), indeterminate (n = 10), and negative for malignancy (n = 8). Selected malignant appearing cytological cell clusters and microdissected histological samples from cancer showed abundant LOH characteristic of malignancy while brushings from nine cases without cancer carried no LOH (pConclusion: LOH and k-ras codon 12 mutation analysis of PCR amplified DNA from biliary brush cytology discriminates reactive from malignant cells, with 100% sensitivity, specificity, and accuracy. Minor variations in LOH in brushings and in different sites within the same tumour likely reflect intratumoral mutational heterogeneity during clonal expansion of pre- and neoplastic lineages.Keywords
This publication has 50 references indexed in Scilit:
- Genetic basis of pancreatic cancerBest Practice & Research Clinical Gastroenterology, 2002
- Multiple loss of heterozygosity without K-ras mutation identified by molecular analysis on fine-needle aspiration cytology specimen of acinar cell carcinoma of pancreasDiagnostic Cytopathology, 2002
- K-ras,p53, andDPC4(MAD4) Alterations in Fine-Needle Aspirates of the PancreasAmerican Journal of Clinical Pathology, 2002
- Pancreatic Intraepithelial NeoplasiaThe American Journal of Surgical Pathology, 2001
- p53 overexpression and K- ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancerJournal of Hepato-Biliary-Pancreatic Surgery, 2000
- Allelotype Analysis of Intrahepatic CholangiocarcinomaLaboratory Investigation, 2000
- Prospective Evaluation of Brush Cytology of Biliary Strictures During Endoscopic Retrograde CholangiopancreatographyEndoscopy, 1999
- DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1Science, 1996
- Cholangiocarcinomas in japanese and thai patients: Difference in etiology and incidence of point mutation of the c‐KI‐ras proto‐oncogeneMolecular Carcinogenesis, 1992
- Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genesPublished by Elsevier ,1988